Clearmind Medicine Inc. Signs Non-Binding Term Sheet with Dr. Glitter Pty Ltd for Development of MEAI-Based Alcohol Substitute
Clearmind and Dr. Glitter Pty Ltd plan to collaborate on a novel alcohol substitute using ActivCrystalâ„¢ technology.Quiver AI SummaryClearmind Medicine Inc. has signed a non-binding term sheet with Dr....
Clearmind Medicine to Present at the LD Micro Main Event XVI Investor Conference on October 4th
Tel Aviv, Israel and Vancouver, British Columbia--(Newsfile Corp. - September 28, 2023) - Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND) (FSE: CWY) ("Clearmind" or the "company"), a biotech company...
Demand for Abuse Deterrent Formulation Technology Skyrocketing as Opiate Abuse is on the Rise
/PRNewswire/ -- The demand for abuse deterrent formulation technology is projected to grow due to growing misuse of drugs among the people. Growing demand for...
Demand for Abuse Deterrent Formulation Technology Skyrocketing as Opiate Abuse is on the Rise
EQNX::TICKER_START (NASDAQ:NTRB),(NASDAQ:CMND),(NASDAQ:MNMD),(NYSE:CYBN),(NYSE:LLY) EQNX::TICKER_END